Screening methods under review

Article

Please click here to read the full story.

Please click here to read the full story.

Related Videos
Related Content
The Public Market in Seattle, Washington. Image credit: ©jayyuan – stock.adobe.com

Plan your visit to Seattle: This year's ARVO meeting promises must-see programming

May 1st 2024
Article

The meeting kicks off with symposia and an opening keynote speech from Ed Yong

Site Logo

Novel Therapies in Neovascular AMD and DME: Achieving Superior Anatomic Outcomes with Fewer Injections

June 29th 2023
Podcast
Data from self-tonometry supports glaucoma treatment decisions

Data from self-tonometry supports glaucoma treatment decisions

May 1st 2024
Article
Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO

Long-Term Efficacy and Durability of Latest Therapies in neovascular AMD and DMO

December 19th 2022
Podcast
Hemoglobin molecule structure, rendered in pink and purple. Generative AI. Image credit: ©Electro Unicorn – stock.adobe.com

TEASE-3 study: Positive interim data are reported for Stargardt drug

April 25th 2024
Article

Gildeuretinol halts Stargardt disease progression, study results indicate

A researcher sits at a computer. Image credit: ©lightpoet – stock.adobe.com

Interactive vision simulator illustrates the vision loss caused by retinal diseases

April 23rd 2024
Article

The online tool shows vision loss simulations for diabetic macular oedema, diabetic retinopathy, age-related macular degeneration and other retinal diseases

© 2024 MJH Life Sciences

All rights reserved.